Gene346
APOC4: apolipoprotein C4
13 sourcesgene-search-2026-11-13-0.2.1
Cite this record
ConductScience Library. APOC4: apolipoprotein C4. Genes, record 346. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/346
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P55056 | Apolipoprotein C-IV | 127 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents193
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 968 | P55056 | Espacenet |
| US 20260201011 A1 | 2026-07-16 | 970 | P55056 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5507 | P55056 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 968 | P55056 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 970 | P55056 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 968 | P55056 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 970 | P55056 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37668 | P55056 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37672 | P55056 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37673 | P55056 | Espacenet |
NIH grants673
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOC4 papers | Newest fiscal year |
|---|---|---|---|
| P30DK017047 | Diabetes Research Center | 7 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 7 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 6 | 2025 |
| U24AG021886 | National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) | 4 | 2025 |
| ZIAHG000024 | Genetic analysis of type II diabetes | 4 | 2025 |
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 3 | 2025 |
| P30DK035816 | Nutrition Obesity Research Center | 3 | 2025 |
| R01DK062370 | Identifying Genes for Type 2 Diabetes: FUSION | 3 | 2025 |
| P01HL151328 | Triglycerides, Diabetes and Cardiovascular Disease | 2 | 2025 |
| P30AG066468 | Alzheimer Disease Research Center | 2 | 2025 |
Source NIH's project files
Papers450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteomic profiling of septic shock and acute pancreatitis identifies shared signatures and disease-specific pathways. | Sci Rep | 2026 | 42702635 | PubTator, text mining | PubMed |
| Serum Proteomic Profiling Reveals Renin-Associated Immune and Cytoskeletal Dysregulation in Post-COVID-19 Condition Patients with Secondary Adrenal Insufficiency. | J Proteome Res | 2026 | 42695868 | PubTator, text mining | PubMed |
| Haplotype-resolved DNA methylation at the APOE locus identifies allele-specific epigenetic signatures relevant to Alzheimer's disease risk. | NPJ Dement | 2026 | 42327426 | PubTator, text mining | PubMed |
| Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population. | Front Cardiovasc Med | 2026 | 42311766 | PubTator, text mining | PubMed |
| Analysis of Purity and Quality of Small Extracellular Vesicles Isolated from Blood Plasma by Proteomics and Raman Spectroscopy. | Biochemistry (Mosc) | 2026 | 41936559 | PubTator, text mining | PubMed |
| APOs as promising prognostic biomarkers: correlation with tumor-infiltrating leukocytes in endometrial cancer. | Front Immunol | 2026 | 41777895 | PubTator, text mining | PubMed |
| Biomarkers of Progressive Chronic Heart Failure: The Results of Blood Proteomic Analysis. | Kardiologiia | 2026 | 41531355 | PubTator, text mining | PubMed |
| Unlocking the power of extracellular vesicles: multi-omics integration for cancer biomarker discovery. | Biomark Res | 2026 | 41527006 | PubTator, text mining | PubMed |
| Unraveling the genetic interplay between sleep disorders and Alzheimer's disease: From shared genes to potential therapeutic targets. | J Affect Disord | 2026 | 41330513 | PubTator, text mining | PubMed |
| A Robust Serum Proteomic Signature of the E2 Allele of Apolipoprotein E. | Adv Sci (Weinh) | 2026 | 41316897 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/346
GET https://conductscience.org/api/genes/v1/346/patents?page=2